What is the recommended treatment with Augmentin (amoxicillin-clavulanate) for a patient with sinusitis and respiratory infection, considering potential allergies to penicillin or other beta-lactam antibiotics?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin for Sinusitis and Respiratory Infection

Amoxicillin-clavulanate (Augmentin) 875 mg/125 mg twice daily for 5-10 days is the preferred first-line antibiotic for acute bacterial sinusitis in adults, providing optimal coverage against beta-lactamase-producing organisms (Haemophilus influenzae, Moraxella catarrhalis) and drug-resistant Streptococcus pneumoniae. 1, 2, 3

When to Start Antibiotics

Before prescribing, confirm the diagnosis meets one of three bacterial criteria: 1, 4

  • Persistent symptoms ≥10 days without improvement (nasal discharge, congestion, facial pain/pressure, or cough) 1, 4
  • Severe symptoms for ≥3 consecutive days (fever ≥39°C/102°F with purulent nasal discharge) 1, 4
  • "Double sickening" - worsening after initial improvement from a viral upper respiratory infection 1, 4

Critical pitfall: 98-99.5% of acute rhinosinusitis is viral and resolves spontaneously within 7-10 days without antibiotics—do not prescribe for symptoms <10 days unless severe. 1

Standard Dosing for Adults

For uncomplicated cases: Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days 1, 2, 5

For high-risk patients (recent antibiotic use within past month, age >65 years, moderate-to-severe symptoms, comorbidities like diabetes/immunosuppression, or geographic areas with high penicillin-resistant S. pneumoniae): High-dose amoxicillin-clavulanate 2000 mg/125 mg twice daily 3, 6

Administration: Take at the start of meals to minimize gastrointestinal side effects and enhance clavulanate absorption. 5

Pediatric Dosing

Standard therapy: Amoxicillin-clavulanate 45 mg/kg/day (of amoxicillin component) divided twice daily 1, 5

High-dose therapy (for children <2 years, daycare attendance, recent antibiotic use, or areas with resistant S. pneumoniae): 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate divided twice daily 1, 3, 6

Duration: 10-14 days or continue for 7 days after symptom resolution 3

For Patients with Penicillin Allergy

Non-severe/delayed-type allergy (rash, mild reactions): Second- or third-generation cephalosporins are safe and preferred 1, 2

  • Cefuroxime-axetil (second-generation): effective in 5-day courses 1, 2
  • Cefpodoxime-proxetil or cefdinir (third-generation): superior activity against H. influenzae, effective in 5 days 1, 2, 7

Severe/Type I hypersensitivity (anaphylaxis): Respiratory fluoroquinolones 1, 3

  • Levofloxacin 500 mg once daily for 10-14 days 1, 3
  • Moxifloxacin 400 mg once daily for 10 days 1, 3

What NOT to use: Azithromycin and other macrolides have 20-25% resistance rates for S. pneumoniae and H. influenzae—explicitly contraindicated as first-line therapy. 1, 7

Treatment Failure Protocol

Reassess at 3-5 days: If no improvement or worsening symptoms, switch antibiotics immediately. 1, 2, 3

Second-line options: 1, 2

  • High-dose amoxicillin-clavulanate 2000 mg/125 mg twice daily (if not already used) 1
  • Respiratory fluoroquinolones (levofloxacin 500-750 mg once daily or moxifloxacin 400 mg once daily) for 10-14 days 1, 2
  • Ceftriaxone 1-2 g IM/IV once daily for 5 days (for patients unable to tolerate oral medications) 8, 1

At 7 days: If symptoms persist, reconfirm diagnosis and consider complications (orbital cellulitis, meningitis) or alternative diagnoses. 1

Essential Adjunctive Therapies

These improve outcomes regardless of antibiotic choice: 1, 3

  • Intranasal corticosteroids (mometasone, fluticasone, or budesonide twice daily): reduce mucosal inflammation and improve symptom resolution 1, 3
  • Saline nasal irrigation: improves sinus drainage and provides symptomatic relief 1, 3
  • Analgesics (acetaminophen, ibuprofen): for pain and fever relief 1, 3
  • Decongestants: provide symptomatic relief, but limit topical use to ≤3 days to avoid rhinitis medicamentosa 2

Expected Timeline for Improvement

  • 3-5 days: Most patients should show noticeable improvement (reduced fever, facial pain, purulent discharge) 1
  • 7 days: 73-85% of patients show clinical improvement 1
  • 10-14 days: Complete resolution typically occurs by this timepoint 1, 3

If no improvement by 3-5 days, this constitutes treatment failure—switch antibiotics immediately. 1, 2

Critical Warnings and Contraindications

Hypersensitivity reactions: Serious and occasionally fatal anaphylactic reactions can occur—inquire about previous penicillin, cephalosporin, or other allergen hypersensitivity before prescribing. 5

Hepatic dysfunction: Monitor liver function in patients with hepatic impairment, as hepatitis and cholestatic jaundice have been reported (usually reversible). 5

Clostridium difficile-associated diarrhea (CDAD): Can occur with amoxicillin-clavulanate use—if suspected, discontinue and treat appropriately. 5

Mononucleosis: Do not administer to patients with mononucleosis due to high risk of erythematous skin rash. 5

Gastrointestinal effects: Most common adverse event is diarrhea (number needed to harm: 8.1)—taking medication at the start of meals minimizes this. 3, 5

Special Considerations by Anatomic Location

Maxillary sinusitis (most common): Standard first-line treatment with amoxicillin-clavulanate 1, 2

Frontal, ethmoidal, or sphenoidal sinusitis: Consider respiratory fluoroquinolones (levofloxacin or moxifloxacin) due to risk of serious complications like meningitis or brain abscess. 1, 2

When to Refer to a Specialist

Refer to otolaryngology for: 1, 4

  • Symptoms refractory to two courses of appropriate antibiotics 1
  • Recurrent sinusitis (≥3 episodes per year) 1
  • Suspected complications (orbital cellulitis, meningitis, abscess) 1, 4
  • Need for sinus aspiration/culture in immunocompromised patients 1

References

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Antibiotic Treatment for Upper Respiratory and Sinusitis Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Bacterial Sinusitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Acute Rhinosinusitis: Rapid Evidence Review.

American family physician, 2025

Research

Beginning antibiotics for acute rhinosinusitis and choosing the right treatment.

Clinical reviews in allergy & immunology, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.